• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION CONTOUR 3D ANNULOPLASTY RING; RING, ANNULOPLASTY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION CONTOUR 3D ANNULOPLASTY RING; RING, ANNULOPLASTY Back to Search Results
Model Number 690R
Device Problem Incomplete Coaptation (2507)
Patient Problems Stroke/CVA (1770); Endocarditis (1834); Heart Block (4444); Tricuspid Valve Insufficiency/ Regurgitation (4453)
Event Date 10/29/2021
Event Type  Injury  
Manufacturer Narrative
Citation: dzilic et al.Results after repair of functional tricuspid regurgitation with a three-dimensional annuloplasty ring.J clin med.2021 oct 29;10(21):5080.Doi: 10.3390/jcm10215080.Earliest date of publish used for date of event.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding results after repair of functional tricuspid regurgitation with a three-dimensional annuloplasty ring.All data were retrospectively collected from a single german medical center between december 2010 and january 2017.The study population included 468 patients (predominantly male, mean age 69.4 years).All patients were implanted with a medtronic contour 3d annuloplasty ring (unique device identifier numbers not provided).Among all patients there were 23 deaths, which included one peri-operative death due to uncontrollable bleeding and 22 deaths within 30 days of implant.Based on the available information medtronic product was not directly associated with the death(s).Among all patients, adverse events included: ischemic stroke, third-degree atrio-ventricular (av) block requiring permanent pacemaker, and reoperation for various cardiac-related issues such as endocarditis and restrictive motion or prolapse of valve leaflet. additionally, severe tricuspid regurgitation was observed at 4 to 6 years post-implant, which the physician/authors stated was comparable with findings of other studies.Based on the available information medtronic product were likely associated with the adverse event(s).No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONTOUR 3D ANNULOPLASTY RING
Type of Device
RING, ANNULOPLASTY
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key13725946
MDR Text Key290289460
Report Number2025587-2022-00654
Device Sequence Number1
Product Code KRH
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K101212
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 03/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/10/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number690R
Device Catalogue Number690R
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/01/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Life Threatening; Hospitalization;
Patient Age69 YR
Patient SexMale
-
-